Fire-Side Chat: Mitigating Pain Points from M&A Transition Whilst Ensuring Business Continuity & Minimized Risk
Time: 9:30 am
day: Day One AM
Details:
- Addressing the challenge of harmonizing diverse needs and processes between pharma and biotech
- Examining the legal and compliance priorities that small biotech companies need to reprioritise during M&A and the crucial role of understanding the lens of larger pharma’s to ensure a smooth transition and business continuity
- Discussing anticipatory measures to mitigate pain points during transitions, emphasizing the importance of collaboration between each party
